Immunolabeling of endomucin+ vessels revealed an approximately 50% reduction in tumor vascularity despite no significant differences in tumor volume, tumor cell proliferation, or apoptosis (Supplementary Fig. S1J–S1Q). Here, EMCN is linked to neoplasm.